Pyxis Oncology
PYXS
$3.66
Share price
-3.43%
Change (1 day)
26.21%
Change (1 year)
Categories
Pyxis Oncology (PYXS) - Cash on Hand
Cash on Hand as of March 2024 : $0.15 B
According to Pyxis Oncology's latest financial reports the company has $0.15 B in cash and cash equivalents.
A company’s cash on hand also refered as cash/cash equivalents (CCE) and Short-term investments, is the amount of accessible money a business has.
Pyxis Oncology - Cash on Hand chart (from 2020 to 2024)
Cash on Hand by year
| Year | Cash on Hand | Change |
|---|---|---|
| 2022-12-31 | $0.17 B | -34.74% |
| 2021-12-31 | $0.27 B | 3300.19% |
| 2020-12-31 | $8.08 M | -58.96% |
| 2019-12-31 | $19.69 M |